These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 33986754)
1. Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer. Peng Y; Yu H; Jin Y; Qu F; Ren H; Tang Z; Zhang Y; Qu C; Zong B; Liu S Front Immunol; 2021; 12():666137. PubMed ID: 33986754 [TBL] [Abstract][Full Text] [Related]
2. A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer. Liu Z; Mi M; Li X; Zheng X; Wu G; Zhang L J Cell Mol Med; 2020 Nov; 24(21):12444-12456. PubMed ID: 32967061 [TBL] [Abstract][Full Text] [Related]
3. Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer. Qiu F; Zhu Y; Shi Y; Ji J; Jin Y Dis Markers; 2021; 2021():4251763. PubMed ID: 34804261 [TBL] [Abstract][Full Text] [Related]
4. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer. Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321 [No Abstract] [Full Text] [Related]
5. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer. Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of a 14 immune-related gene pair signature to predict the prognosis and immune features of gastric cancer. Liu C; Chen B; Huang Z; Hu C; Jiang L; Zhao C Int Immunopharmacol; 2020 Dec; 89(Pt B):107074. PubMed ID: 33049494 [TBL] [Abstract][Full Text] [Related]
7. Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction. Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B DNA Cell Biol; 2019 Dec; 38(12):1529-1539. PubMed ID: 31647329 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of a prognostic signature of breast cancer based on drug absorption, distribution, metabolism and excretion (ADME)-related genes. Wu Z; Guo Y; Qu L; Wang X; Zhang H Sci Rep; 2024 Sep; 14(1):21619. PubMed ID: 39284852 [TBL] [Abstract][Full Text] [Related]
9. Development and Validation of Tumor Immunogenicity Based Gene Signature for Skin Cancer Risk Stratification. Yavartanoo M; Yi GS Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769455 [TBL] [Abstract][Full Text] [Related]
10. Eight immune-related genes predict survival outcomes and immune characteristics in breast cancer. Xu H; Wang G; Zhu L; Liu H; Li B Aging (Albany NY); 2020 Aug; 12(16):16491-16513. PubMed ID: 32756008 [TBL] [Abstract][Full Text] [Related]
11. Clinical significance and immunogenomic landscape analyses of the immune cell signature based prognostic model for patients with breast cancer. Wang S; Xiong Y; Zhang Q; Su D; Yu C; Cao Y; Pan Y; Lu Q; Zuo Y; Yang L Brief Bioinform; 2021 Jul; 22(4):. PubMed ID: 33302293 [TBL] [Abstract][Full Text] [Related]
12. Identifying SLC2A6 as the novel protective factor in breast cancer by TP53-related genes affecting M1 macrophage infiltration. Dai C; Man Y; Zhang L; Zhang X; Xie C; Wang S; Zhang Y; Guo Q; Zou L; Hong H; Jiang L; Shi Y Apoptosis; 2024 Aug; 29(7-8):1211-1231. PubMed ID: 38622369 [TBL] [Abstract][Full Text] [Related]
13. Insights into a Machine Learning-Based Palmitoylation-Related Gene Model for Predicting the Prognosis and Treatment Response of Breast Cancer Patients. Zhu H; Hu H; Hao B; Zhan W; Yan T; Zhang J; Wang S; Hu H; Zhang T Technol Cancer Res Treat; 2024; 23():15330338241263434. PubMed ID: 39205467 [TBL] [Abstract][Full Text] [Related]
14. A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma. Yu H; Fu Y; Tang Z; Jiang L; Qu C; Li H; Tan Z; Shu D; Peng Y; Liu S Aging (Albany NY); 2022 Jan; 14(2):989-1013. PubMed ID: 35085103 [TBL] [Abstract][Full Text] [Related]
15. Metabolic gene signature for predicting breast cancer recurrence using transcriptome analysis. Feng J; Ren J; Yang Q; Liao L; Cui L; Gong Y; Sun S Future Oncol; 2021 Jan; 17(1):71-80. PubMed ID: 33397130 [No Abstract] [Full Text] [Related]
16. Development and validation of an immune gene-set based prognostic signature for soft tissue sarcoma. Shen R; Liu B; Li X; Yu T; Xu K; Ma J BMC Cancer; 2021 Feb; 21(1):144. PubMed ID: 33557781 [TBL] [Abstract][Full Text] [Related]
17. Exploring the significance of novel immune-related gene signatures in the prognosis and immune features of pancreatic adenocarcinoma. Chen B; Hu C; Jiang L; Xiang Z; Zuo Z; Lin Y; Liu C Int Immunopharmacol; 2021 Mar; 92():107359. PubMed ID: 33465729 [TBL] [Abstract][Full Text] [Related]
18. A ubiquitin-proteasome system-related signature to predict prognosis, immune infiltration, and therapy efficacy for breast cancer. Liu X; Wang M; Wang Q; Zhang H Immunol Res; 2024 Jun; 72(3):368-382. PubMed ID: 38036900 [TBL] [Abstract][Full Text] [Related]
19. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients. Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792 [TBL] [Abstract][Full Text] [Related]
20. Identification of hepatocellular carcinoma prognostic markers based on 10-immune gene signature. Zhao K; Xu L; Li F; Ao J; Jiang G; Shi R; Chen F; Luo Q Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32789471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]